Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017 (2017), Article ID 9671604, 14 pages
https://doi.org/10.1155/2017/9671604
Review Article

Neutrophils and Immunity: From Bactericidal Action to Being Conquered

1School of Medical Sciences, College of Medicine, Henan University, Kaifeng, Henan 475004, China
2Nanshi Hospital, Henan University College of Medicine, Nanyang, Henan 453003, China

Correspondence should be addressed to Xin-Ying Ji

Received 15 December 2016; Accepted 29 January 2017; Published 19 February 2017

Academic Editor: Clifford Lowell

Copyright © 2017 Tie-Shan Teng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Borregaard, “Neutrophils, from marrow to microbes,” Immunity, vol. 33, no. 5, pp. 657–670, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. P. H. C. Leliefeld, C. M. Wessels, L. P. H. Leenen, L. Koenderman, and J. Pillay, “The role of neutrophils in immune dysfunction during severe inflammation,” Critical Care, vol. 20, no. 1, article 73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Nathan, “Neutrophils and immunity: challenges and opportunities,” Nature Reviews Immunology, vol. 6, no. 3, pp. 173–182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. T. N. Mayadas, X. Cullere, and C. A. Lowell, “The multifaceted functions of neutrophils,” Annual Review of Pathology: Mechanisms of Disease, vol. 9, pp. 181–218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. W. Segal, “How neutrophils kill microbes,” Annual Review of Immunology, vol. 23, pp. 197–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. C. F. Urban, S. Lourido, and A. Zychlinsky, “How do microbes evade neutrophil killing?” Cellular Microbiology, vol. 8, no. 11, pp. 1687–1696, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Döhrmann, J. N. Cole, and V. Nizet, “Conquering neutrophils,” PLoS Pathogens, vol. 12, no. 7, Article ID e1005682, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. W. M. Nauseef, “Neutrophils, from cradle to grave and beyond,” Immunological Reviews, vol. 273, no. 1, pp. 5–10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. K. M. Rigby and F. R. DeLeo, “Neutrophils in innate host defense against Staphylococcus aureus infections,” Seminars in Immunopathology, vol. 34, no. 2, pp. 237–259, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. R. Dunkelberger and W.-C. Song, “Complement and its role in innate and adaptive immune responses,” Cell Research, vol. 20, no. 1, pp. 34–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. P. M. van Kesse, J. Bestebroer, and J. A. G. van Strijp, “Neutrophil-mediated phagocytosis of Staphylococcus aureus,” Frontiers in Immunology, vol. 5, article 467, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. W. Ford and D. W. McVicar, “TREM and TREM-like receptors in inflammation and disease,” Current Opinion in Immunology, vol. 21, no. 1, pp. 38–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Mócsai, “Diverse novel functions of neutrophils in immunity, inflammation, and beyond,” The Journal of Experimental Medicine, vol. 210, no. 7, pp. 1283–1299, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Amulic, C. Cazalet, G. L. Hayes, K. D. Metzler, and A. Zychlinsky, “Neutrophil function: from mechanisms to disease,” Annual Review of Immunology, vol. 30, pp. 459–489, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Roos, R. van Bruggen, and C. Meischl, “Oxidative killing of microbes by neutrophils,” Microbes and Infection, vol. 5, no. 14, pp. 1307–1315, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Greenlee-Wacker, F. R. DeLeo, and W. M. Nauseef, “How methicillin-resistant Staphylococcus aureus evade neutrophil killing,” Current Opinion in Hematology, vol. 22, no. 1, pp. 30–35, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Odobasic, A. R. Kitching, and S. R. Holdsworth, “Neutrophil-mediated regulation of innate and adaptive immunity: the role of myeloperoxidase,” Journal of Immunology Research, vol. 2016, Article ID 2349817, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. Klebanoff, “Myeloperoxidase: friend and foe,” Journal of Leukocyte Biology, vol. 77, no. 5, pp. 598–625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. V. I. Morozov, S. A. Pryatkin, M. I. Kalinski, and V. A. Rogozkin, “Effect of exercise to exhaustion on myeloperoxidase and lysozyme release from blood neutrophils,” European Journal of Applied Physiology, vol. 89, no. 3-4, pp. 257–262, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. C. C. Winterbourn, A. J. Kettle, and M. B. Hampton, “Reactive oxygen species and neutrophil function,” Annual Review of Biochemistry, vol. 85, pp. 765–792, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Cardot-Martin, J. S. Casalegno, C. Badiou et al., “α-defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureus,” Letters in Applied Microbiology, vol. 61, no. 2, pp. 158–164, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Frasca and R. Lande, “Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseases,” Current Pharmaceutical Biotechnology, vol. 13, no. 10, pp. 1882–1897, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Wu, L. Liu, M. Lin et al., “Importance of the residue 190 on bactericidal activity of the bactericidal/permeability-increasing protein 5,” Oncotarget, vol. 7, no. 28, pp. 43088–43094, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Schuerholz, K. Brandenburg, and G. Marx, “Antimicrobial peptides and their potential application in inflammation and sepsis,” Critical Care, vol. 16, no. 2, article 207, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. C. B. Park, K.-S. Yi, K. Matsuzaki, M. S. Kim, and S. C. Kim, “Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 15, pp. 8245–8250, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. J. A. Nash, T. N. S. Ballard, T. E. Weaver, and H. T. Akinbi, “The peptidoglycan-degrading property of lysozyme is not required for bactericidal activity in vivo,” The Journal of Immunology, vol. 177, no. 1, pp. 519–526, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. A. C. Stapels, B. V. Geisbrecht, and S. H. M. Rooijakkers, “Neutrophil serine proteases in antibacterial defense,” Current Opinion in Microbiology, vol. 23, pp. 42–28, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Ginsburg, “The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae,” APMIS, vol. 110, no. 11, pp. 753–770, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Korkmaz, M. S. Horwitz, D. E. Jenne, and F. Gauthier, “Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases,” Pharmacological Reviews, vol. 62, no. 4, pp. 726–759, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Kasperkiewicz, M. Poreba, S. J. Snipas et al., “Design of a selective substrate and activity based probe for human neutrophil serine protease 4,” PLOS ONE, vol. 10, no. 7, Article ID e0132818, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. N. C. Perera, O. Schilling, H. Kittel, W. Back, E. Kremmer, and D. E. Jenne, “NSP4, an elastase-related protease in human neutrophils with arginine specificity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 16, pp. 6229–6234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. N. C. Perera, K.-H. Wiesmüller, M. T. Larsen et al., “NSP4 is stored in azurophil granules and released by activated neutrophils as active endoprotease with restricted specificity,” Journal of Immunology, vol. 191, no. 5, pp. 2700–2707, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Watorek, “Azurocidin—inactive serine proteinase homolog acting as a multifunctional inflammatory mediator,” Acta Biochimica Polonica, vol. 50, no. 3, pp. 743–752, 2003. View at Google Scholar · View at Scopus
  34. D. Legrand, “Overview of lactoferrin as a natural immune modulator,” Journal of Pediatrics, vol. 173, supplement, pp. S10–S15, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Farnaud and R. W. Evans, “Lactoferrin—a multifunctional protein with antimicrobial properties,” Molecular Immunology, vol. 40, no. 7, pp. 395–405, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Caccavo, N. M. Pellegrino, M. Altamura et al., “Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application,” Journal of Endotoxin Research, vol. 8, no. 6, pp. 403–417, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Okubo, M. Kamiya, Y. Urano et al., “Lactoferrin suppresses neutrophil extracellular traps release in inflammation,” EBioMedicine, vol. 10, pp. 204–215, 2016. View at Publisher · View at Google Scholar
  38. T. E. Kehl-Fie, S. Chitayat, M. I. Hood et al., “Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus,” Cell Host and Microbe, vol. 10, no. 2, pp. 158–164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. R. D'Incà, E. Pont, V. Leo et al., “Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease,” International Journal of Colorectal Disease, vol. 22, no. 4, pp. 429–437, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Daigo, N. Yamaguchi, T. Kawamura et al., “The proteomic profile of circulating pentraxin 3 (PTX3) complex in sepsis demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular traps,” Molecular & Cellular Proteomics, vol. 11, no. 6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A. P. Levine and A. W. Segal, “The NADPH oxidase and microbial killing by neutrophils, with a particular emphasis on the proposed antimicrobial role of myeloperoxidase within the phagocytic vacuole,” Microbiology Spectrum, vol. 4, no. 4, 2016. View at Google Scholar
  42. W. Theeß, J. Sellau, C. Steeg et al., “Myeloperoxidase attenuates pathogen clearance during Plasmodium yoelii nonlethal infection,” Infection and Immunity, vol. 85, no. 1, Article ID e00475-16, 2016. View at Publisher · View at Google Scholar
  43. S. J. Klebanoff, A. J. Kettle, H. Rosen, C. C. Winterbourn, and W. M. Nauseef, “Myeloperoxidase: a front-line defender against phagocytosed microorganisms,” Journal of Leukocyte Biology, vol. 93, no. 2, pp. 185–198, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Carestia, T. Kaufman, and M. Schattner, “Platelets: new bricks in the building of neutrophil extracellular traps,” Frontiers in Immunology, vol. 7, article 271, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. K. M. Schmidt-Ott, K. Mori, Y. L. Jau et al., “Dual action of neutrophil gelatinase-associated lipocalin,” Journal of the American Society of Nephrology, vol. 18, no. 2, pp. 407–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Chakraborty, S. Kaur, S. Guha, and S. K. Batra, “The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1826, no. 1, pp. 129–169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Bestebroer, M. J. J. G. Poppelier, L. H. Ulfman et al., “Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling,” Blood, vol. 109, no. 7, pp. 2936–2943, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Bestebroer, K. P. M. Van Kessel, H. Azouagh et al., “Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins,” Blood, vol. 113, no. 2, pp. 328–337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Fevre, J. Bestebroer, M. M. Mebius et al., “Staphylococcus aureus proteins SSL6 and SElX interact with neutrophil receptors as identified using secretome phage display,” Cellular Microbiology, vol. 16, no. 11, pp. 1646–1665, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. M. C. Chung, B. D. Wines, H. Baker, R. J. Langley, E. N. Baker, and J. D. Fraser, “The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition,” Molecular Microbiology, vol. 66, no. 6, pp. 1342–1355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. B. W. Bardoel, R. Vos, T. Bouman et al., “Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3,” Journal of Molecular Medicine, vol. 90, no. 10, pp. 1109–1120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. K. J. Koymans, L. J. Feitsma, T. H. C. Brondijk et al., “Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3),” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 35, pp. 11018–11023, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. A. J. Laarman, G. Mijnheer, J. M. Mootz et al., “Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis,” EMBO Journal, vol. 31, no. 17, pp. 3607–3619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. P.-J. Haas, C. J. C. De Haas, W. Kleibeuker et al., “N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor,” Journal of Immunology, vol. 173, no. 9, pp. 5704–5711, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. P.-J. Haas, C. J. C. De Haas, M. J. J. C. Poppelier et al., “The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules,” Journal of Molecular Biology, vol. 353, no. 4, pp. 859–872, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Kretschmer, A.-K. Gleske, M. Rautenberg et al., “Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus,” Cell Host and Microbe, vol. 7, no. 6, pp. 463–473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. S. D. Kobayashi, K. R. Braughton, A. M. Palazzolo-Ballance et al., “Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus,” Journal of Innate Immunity, vol. 2, no. 6, pp. 560–575, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Wang, K. R. Braughton, D. Kretschmer et al., “Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA,” Nature Medicine, vol. 13, no. 12, pp. 1510–1514, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Chavakis, M. Hussain, S. M. Kanse et al., “Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes,” Nature Medicine, vol. 8, no. 7, pp. 687–693, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. A. J. Laarman, M. Ruyken, C. L. Malone, J. A. G. van Strijp, A. R. Horswill, and S. H. M. Rooijakkers, “Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion,” The Journal of Immunology, vol. 186, no. 11, pp. 6445–6453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. S. H. M. Rooijakkers, M. Ruyken, A. Roos et al., “Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases,” Nature Immunology, vol. 6, no. 9, pp. 920–927, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. S. H. M. Rooijakkers, J. Wu, M. Ruyken et al., “Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor,” Nature Immunology, vol. 10, no. 7, pp. 721–727, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Y. L. Lee, M. Höök, D. Haviland et al., “Inhibition of complement activation by a secreted Staphylococcus aureus protein,” Journal of Infectious Diseases, vol. 190, no. 3, pp. 571–579, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. I. Jongerius, B. L. Garcia, B. V. Geisbrecht, J. A. G. Van Strijp, and S. H. M. Rooijakkers, “Convertase inhibitory properties of staphylococcal extracellular complement-binding protein,” Journal of Biological Chemistry, vol. 285, no. 20, pp. 14973–14979, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Bestebroer, P. C. Aerts, S. H. M. Rooijakkers et al., “Functional basis for complement evasion by staphylococcal superantigen-like 7,” Cellular Microbiology, vol. 12, no. 10, pp. 1506–1516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. A. M. E. Walenkamp, I. G. J. Boer, J. Bestebroer et al., “Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration,” Neoplasia, vol. 11, no. 4, pp. 333–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. S. H. M. Rooijakkers, W. J. B. Van Wamel, M. Ruyken, K. P. M. Van Kessel, and J. A. G. Van Strijp, “Anti-opsonic properties of staphylokinase,” Microbes and Infection, vol. 7, no. 3, pp. 476–484, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Haupt, M. Reuter, J. van den Elsen et al., “The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b,” PLoS Pathogens, vol. 4, no. 12, Article ID e1000250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. J. D. Burman, E. Leung, K. L. Atkins et al., “Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus,” The Journal of Biological Chemistry, vol. 283, no. 25, pp. 17579–17593, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. H. K. Kim, A. G. Cheng, H.-Y. Kim, D. M. Missiakas, and O. Schneewind, “Nontoxigenic protein A vaccine for methicillin-resistant staphylococcus aureus infections in mice,” Journal of Experimental Medicine, vol. 207, no. 9, pp. 1863–1870, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. N. Malachowa, P. L. Kohler, P. M. Schlievert et al., “Characterization of a staphylococcus aureus surface virulence factor that promotes resistance to oxidative killing and infectious endocarditis,” Infection and Immunity, vol. 79, no. 1, pp. 342–352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. J. S. Nanra, S. M. Buitrago, S. Crawford et al., “Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus,” Human Vaccines and Immunotherapeutics, vol. 9, no. 3, pp. 480–487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. J. A. Sharp, C. G. Echague, P. S. Hair et al., “Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic,” PLoS ONE, vol. 7, no. 5, Article ID e38407, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. L. Visai, N. Yanagisawa, E. Josefsson et al., “Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein IsdH,” Microbiology, vol. 155, no. 3, pp. 667–679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. Zong, Y. Xu, X. Liang et al., “A ‘Collagen Hug’ model for Staphylococcus aureus CNA binding to collagen,” The EMBO Journal, vol. 24, no. 24, pp. 4224–4236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. A. L. DuMont, P. Yoong, B. G. J. Surewaard et al., “Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophils,” Infection and Immunity, vol. 81, no. 5, pp. 1830–1841, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. F. Alonzo III, L. Kozhaya, S. A. Rawlings et al., “CCR5 is a receptor for Staphylococcus aureus leukotoxin ED,” Nature, vol. 493, no. 7430, pp. 51–55, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. C. L. Ventura, N. Malachowa, C. H. Hammer et al., “Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics,” PLoS ONE, vol. 5, no. 7, Article ID e11634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. A. N. Spaan, T. Henry, W. J. M. Van Rooijen et al., “The staphylococcal toxin panton-valentine leukocidin targets human C5a receptors,” Cell Host and Microbe, vol. 13, no. 5, pp. 584–594, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. I. Inoshima, N. Inoshima, G. A. Wilke et al., “A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice,” Nature Medicine, vol. 17, no. 10, pp. 1310–1314, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Clauditz, A. Resch, K.-P. Wieland, A. Peschel, and F. Götz, “Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress,” Infection and Immunity, vol. 74, no. 8, pp. 4950–4953, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. K. Cosgrove, G. Coutts, I.-M. Jonsson et al., “Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus,” Journal of Bacteriology, vol. 189, no. 3, pp. 1025–1035, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. Y. Y. Pang, J. Schwartz, S. Bloomberg, J. M. Boyd, A. R. Horswill, and W. M. Nauseef, “Methionine sulfoxide reductases protect against oxidative stress in staphylococcus aureus encountering exogenous oxidants and human neutrophils,” Journal of Innate Immunity, vol. 6, no. 3, pp. 353–364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. V. Thammavongsa, O. Schneewind, and D. M. Missiakas, “Enzymatic properties of Staphylococcus aureus adenosine synthase (AdsA),” BMC Biochemistry, vol. 12, no. 1, article 56, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. J. E. Cassat and E. P. Skaar, “Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity,” Seminars in Immunopathology, vol. 34, no. 2, pp. 215–235, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Bera, S. Herbert, A. Jakob, W. Vollmer, and F. Götz, “Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus,” Molecular Microbiology, vol. 55, no. 3, pp. 778–787, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Herbert, A. Bera, C. Nerz et al., “Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci,” PLoS Pathogens, vol. 3, no. 7, p. e102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. D. A. C. Stapels, K. X. Ramyar, M. Bischoff et al., “Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 36, pp. 13187–13192, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. E. T. M. Berends, A. R. Horswill, N. M. Haste, M. Monestier, V. Nizet, and M. Von Köckritz-Blickwede, “Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps,” Journal of Innate Immunity, vol. 2, no. 6, pp. 576–586, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Schreiber, C. T. N. Pham, Y. Hu, W. Schneider, F. C. Luft, and R. Kettritz, “Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis,” Journal of the American Society of Nephrology, vol. 23, no. 3, pp. 470–482, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. G. Canny and O. Levy, “Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites,” Trends in Immunology, vol. 29, no. 11, pp. 541–547, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. B. D. Corbin, E. H. Seeley, A. Raab et al., “Metal chelation and inhibition of bacterial growth in tissue abscesses,” Science, vol. 319, no. 5865, pp. 962–965, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. N. D. Embleton, J. E. Berrington, W. McGuire, C. J. Stewart, and S. P. Cummings, “Lactoferrin: antimicrobial activity and therapeutic potential,” Seminars in Fetal and Neonatal Medicine, vol. 18, no. 3, pp. 143–149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. S. Mayeur, S. Spahis, Y. Pouliot, and E. Levy, “Lactoferrin, a pleiotropic protein in health and disease,” Antioxidants & Redox Signaling, vol. 24, no. 14, pp. 813–836, 2016. View at Publisher · View at Google Scholar · View at Scopus
  95. J. H. Brock, “Lactoferrin—50 years on,” Biochemistry and Cell Biology, vol. 90, no. 3, pp. 245–251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. V. Brinkmann, U. Reichard, C. Goosmann et al., “Neutrophil extracellular traps kill bacteria,” Science, vol. 303, no. 5663, pp. 1532–1535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. J. Bestebroer, K. P. van Kessel, H. Azouagh et al., “Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins,” Blood, vol. 113, no. 2, pp. 328–337, 2009. View at Publisher · View at Google Scholar
  98. B. McDonald, R. Urrutia, B. G. Yipp, C. N. Jenne, and P. Kubes, “Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis,” Cell Host & Microbe, vol. 12, no. 3, pp. 324–333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. C. G. Baums and M. von Köckritz-Blickwede, “Novel role of DNA in neutrophil extracellular traps,” Trends in Microbiology, vol. 23, no. 6, pp. 330–331, 2015. View at Publisher · View at Google Scholar · View at Scopus
  100. T. A. Fuchs, U. Abed, C. Goosmann et al., “Novel cell death program leads to neutrophil extracellular traps,” Journal of Cell Biology, vol. 176, no. 2, pp. 231–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. H. Yang, M. H. Biermann, J. M. Brauner, Y. Liu, Y. Zhao, and M. Herrmann, “New insights into neutrophil extracellular traps: mechanisms of formation and role in inflammation,” Frontiers in Immunology, vol. 7, article 302, 2016. View at Publisher · View at Google Scholar
  102. B. Amulic and G. Hayes, “Neutrophil extracellular traps,” Current Biology, vol. 21, no. 9, pp. R297–R298, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. V. Thammavongsa, H. K. Kim, D. Missiakas, and O. Schneewind, “Staphylococcal manipulation of host immune responses,” Nature Reviews Microbiology, vol. 13, no. 9, pp. 529–543, 2015. View at Publisher · View at Google Scholar · View at Scopus
  104. K. Ley, C. Laudanna, M. I. Cybulsky, and S. Nourshargh, “Getting to the site of inflammation: the leukocyte adhesion cascade updated,” Nature Reviews Immunology, vol. 7, no. 9, pp. 678–689, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. B. Postma, M. J. Poppelier, J. C. Van Galen et al., “Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor,” Journal of Immunology, vol. 172, no. 11, pp. 6994–7001, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. W. J. B. Van Wamel, S. H. M. Rooijakkers, M. Ruyken, K. P. M. Van Kessel, and J. A. G. Van Strijp, “The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on β-hemolysin-converting bacteriophages,” Journal of Bacteriology, vol. 188, no. 4, pp. 1310–1315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. B. W. Bardoel, E. F. Kenny, G. Sollberger, and A. Zychlinsky, “The balancing act of neutrophils,” Cell Host and Microbe, vol. 15, no. 5, pp. 526–536, 2014. View at Publisher · View at Google Scholar · View at Scopus
  108. W. McGuinness, S. Kobayashi, and F. DeLeo, “Evasion of neutrophil killing by Staphylococcus aureus,” Pathogens, vol. 5, no. 1, p. 32, 2016. View at Publisher · View at Google Scholar
  109. S. H. M. Rooijakkers and J. A. G. van Strijp, “Bacterial complement evasion,” Molecular Immunology, vol. 44, no. 1–3, pp. 23–32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. J. D. Burman, E. Leung, K. L. Atkins et al., “Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus,” Journal of Biological Chemistry, vol. 283, no. 25, pp. 17579–17593, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. E. J. Smith, R. M. Corrigan, T. van der Sluis et al., “The immune evasion protein Sbi of Staphylococcus aureus occurs both extracellularly and anchored to the cell envelope by binding lipoteichoic acid,” Molecular Microbiology, vol. 83, no. 4, pp. 789–804, 2012. View at Publisher · View at Google Scholar · View at Scopus
  112. E. J. Smith, L. Visai, S. W. Kerrigan, P. Speziale, and T. J. Foster, “The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus,” Infection and Immunity, vol. 79, no. 9, pp. 3801–3809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. Y.-P. Ko, A. Kuipers, C. M. Freitag et al., “Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface,” PLOS Pathogens, vol. 9, no. 12, Article ID e1003816, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. P. S. Hair, C. G. Echague, A. M. Sholl et al., “Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis,” Infection and Immunity, vol. 78, no. 4, pp. 1717–1727, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. P. S. Hair, M. D. Ward, O. J. Semmes, T. J. Foster, and K. M. Cunnion, “Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b,” The Journal of Infectious Diseases, vol. 198, no. 1, pp. 125–133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. J. Higgins, A. Loughman, K. P. M. Van Kessel, J. A. G. Van Strijp, and T. J. Foster, “Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes,” FEMS Microbiology Letters, vol. 258, no. 2, pp. 290–296, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. T. J. Foster, J. A. Geoghegan, V. K. Ganesh, and M. Höök, “Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus,” Nature Reviews Microbiology, vol. 12, no. 1, pp. 49–62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. F. E. Guerra, C. B. Addison, N. W. de Jong et al., “Staphylococcus aureus SaeR/S-regulated factors reduce human neutrophil reactive oxygen species production,” Journal of Leukocyte Biology, vol. 100, no. 5, pp. 1005–1010, 2016. View at Publisher · View at Google Scholar
  119. V. Thammavongsa, J. W. Kern, D. M. Missiakas, and O. Schneewind, “Staphylococcus aureus synthesizes adenosine to escape host immune responses,” The Journal of Experimental Medicine, vol. 206, no. 11, pp. 2417–2427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. B. N. Cronstein, L. Daguma, D. Nichols, A. J. Hutchison, and M. Williams, “The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O-2 generation, respectively,” Journal of Clinical Investigation, vol. 85, no. 4, pp. 1150–1157, 1990. View at Publisher · View at Google Scholar · View at Scopus
  121. D. Legrand, “Overview of lactoferrin as a natural immune modulator,” The Journal of Pediatrics, vol. 173, pp. S10–S15, 2016. View at Publisher · View at Google Scholar · View at Scopus
  122. S. R. Clarke and S. J. Foster, “IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin,” Infection and Immunity, vol. 76, no. 4, pp. 1518–1526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. A. Mayer-Scholl, P. Averhoff, and A. Zychlinsky, “How do neutrophils and pathogens interact?” Current Opinion in Microbiology, vol. 7, no. 1, pp. 62–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  124. A. do Vale, D. Cabanes, and S. Sousa, “Bacterial toxins as pathogen weapons against phagocytes,” Frontiers in Microbiology, vol. 7, article 42, 2016. View at Publisher · View at Google Scholar · View at Scopus
  125. A. Peschel and M. Otto, “Phenol-soluble modulins and staphylococcal infection,” Nature Reviews Microbiology, vol. 11, no. 10, pp. 667–673, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. B. G. J. Surewaard, C. J. C. De Haas, F. Vervoort et al., “Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis,” Cellular Microbiology, vol. 15, no. 8, pp. 1427–1437, 2013. View at Publisher · View at Google Scholar · View at Scopus
  127. M. Otto, “Phenol-soluble modulins,” International Journal of Medical Microbiology, vol. 304, no. 2, pp. 164–169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  128. A.-L. Genestier, M.-C. Michallet, G. Prévost et al., “Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils,” Journal of Clinical Investigation, vol. 115, no. 11, pp. 3117–3127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  129. B. Löffler, M. Hussain, M. Grundmeier et al., “Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils,” PLoS Pathogens, vol. 6, no. 1, Article ID e1000715, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. B. K. Dhakal and M. A. Mulvey, “The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways,” Cell Host and Microbe, vol. 11, no. 1, pp. 58–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. B. J. Berube and J. B. Wardenburg, “Staphylococcus aureus α-toxin: nearly a century of intrigue,” Toxins, vol. 5, no. 6, pp. 1140–1166, 2013. View at Publisher · View at Google Scholar · View at Scopus
  132. A. H. Bartlett, T. J. Foster, A. Hayashida, and P. W. Park, “α-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia,” Journal of Infectious Diseases, vol. 198, no. 10, pp. 1529–1535, 2008. View at Publisher · View at Google Scholar · View at Scopus
  133. V. Thammavongsa, D. M. Missiakas, and O. Schneewind, “Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death,” Science, vol. 342, no. 6160, pp. 863–866, 2013. View at Publisher · View at Google Scholar · View at Scopus
  134. A. N. Spaan, B. G. J. Surewaard, R. Nijland, and J. A. G. van Strijp, “Neutrophils versus Staphylococcus aureus: a biological tug of war,” Annual Review of Microbiology, vol. 67, no. 1, pp. 629–650, 2013. View at Publisher · View at Google Scholar · View at Scopus
  135. R. Corriden, A. Hollands, J. Olson et al., “Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramide,” Nature Communications, vol. 6, article no. 8369, 2015. View at Publisher · View at Google Scholar · View at Scopus
  136. A. Hollands, R. Corriden, G. Gysler et al., “Natural product anacardic acid from cashew nut shells stimulates neutrophil extracellular trap production and bactericidal activity,” The Journal of Biological Chemistry, vol. 291, no. 27, pp. 13964–13973, 2016. View at Publisher · View at Google Scholar · View at Scopus